Skip to search.
 FTSE 100 Down 0.32%

More On AZN

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

AstraZeneca PLC (AZN)

-NYSE
69.77 Down 0.74(1.05%) 26 Mar 20:06
|Pre-Market : 70.34 Up 0.57 (0.82%) 11:33
Add to Portfolio
Prev Close:70.51
Open:70.28
Bid:70.14 x 2100
Ask:70.21 x 1800
1y Target Est:75.73
Beta:0.86
Next Earnings Date:N/A
Day's Range:69.55 - 70.28
52wk Range:61.80 - 82.68
Volume:898,141
Avg Vol (3m):1,658,900
Market Cap:88.13b
P/E (ttm):71.41
EPS (ttm):0.98
Div & Yield:3.80 (5.50%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 1.05%88.13b
GSKDown 1.46%112.24b
MRKDown 1.13%163.48b
PFEDown 0.41%209.36b

Key Statistics

Forward P/E (1 yr):17.27
P/S (ttm):3.41
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :4.24
Quarterly EPS Est (Mar-15) :1.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-167.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback